2.16
-0.04(-1.82%)
Currency In USD
| Previous Close | 2.2 |
| Open | 2.18 |
| Day High | 2.22 |
| Day Low | 2.1 |
| 52-Week High | 5.92 |
| 52-Week Low | 0.6 |
| Volume | 884,204 |
| Average Volume | 1.44M |
| Market Cap | 147.93M |
| PE | -2.6 |
| EPS | -0.83 |
| Moving Average 50 Days | 2.88 |
| Moving Average 200 Days | 3.71 |
| Change | -0.04 |
If you invested $1000 in Neuronetics, Inc. (STIM) since IPO date, it would be worth $77.75 as of November 13, 2025 at a share price of $2.16. Whereas If you bought $1000 worth of Neuronetics, Inc. (STIM) shares 5 years ago, it would be worth $302.52 as of November 13, 2025 at a share price of $2.16.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression
GlobeNewswire Inc.
Yesterday at 3:33 PM GMT
New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 StatesMALVERN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and m
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
GlobeNewswire Inc.
Oct 30, 2025 12:32 PM GMT
New collaboration provides services to streamline patient support, reduce administrative burden, and expand access to advanced TMS treatment across Elite DNA ClinicsMALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a
Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call
GlobeNewswire Inc.
Oct 21, 2025 12:30 PM GMT
MALVERN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disord